5′-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors

Journal of Biological Chemistry

Volumn 289, Issue 33, 2014, Pages 22850-22864

  Laderoute, Keith R ^a,g   Calaoagan, Joy M ^a,h   Chao, Wan Ru ^a   Dinh, Dominc ^a   Denko, Nicholas ^b   Duellman, Sarah ^a   Kalra, Jessica ^c   Liu, Xiaohe ^a   Papandreou, Ioanna ^b   Sambucetti, Lidia ^a   Boros, Laszlo G ^d,e,f  

^a SRI INTERNATIONAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c LANGARA COLLEGE   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f SIDMAP LLC   (United States)

^g Imago BioSciences   (United States)

^h PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; GLUCOSE; METABOLISM; PHYSIOLOGY; TISSUE HOMEOSTASIS;

AMP-ACTIVATED PROTEIN KINASE; GLUCOSE HOMEOSTASIS; HUMAN BREAST CANCER; HUMAN BREAST CANCER CELLS; METABOLIC PHENOTYPE; METABOLIC PROFILING; MOUSE EMBRYO FIBROBLASTS; PRIMARY BRAIN TUMORS;

TUMORS;

5' AMP ACTIVATED PROTEIN KINASE; CARBON 13; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PENTOSE PHOSPHATE; UNCLASSIFIED DRUG; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL LINE; CANCER GROWTH; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; ENZYMOLOGY; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PENTOSE PHOSPHATE CYCLE; RAT; TUMOR CELL LINE; XENOGRAFT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GLUCOSE; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PENTOSE PHOSPHATE PATHWAY; RATS;

EID: 84905962247     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.576371     Document Type: Article

References (39)

1. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033
2. Schulze, A., and Harris, A. L. (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-373
3. Metallo, C. M., and Vander Heiden, M. G. (2013) Understanding metabolic regulation and its influence on cell physiology. Mol. Cell 49, 388-398
4. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
5. Saggar, J. K., Yu, M., Tan, Q., and Tannock, I. F. (2013) The tumor microenvironment and strategies to improve drug distribution. Front. Oncol. 3, 154
6. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
7. Yuan, H. X., Xiong, Y., and Guan, K. L. (2013) Nutrient sensing, metabolism, and cell growth control. Mol. Cell 49, 379-387
8. Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J., Foretz, M., and Viollet, B. (2006) 5′-AMP-activated protein kinase (AMPK) is induced by low oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol. Cell. Biol. 26, 5336-5347 (Pubitemid 44036203)
9. Jang, T., Calaoagan, J. M., Kwon, E., Samuelsson, S., Recht, L., and Laderoute, K. R. (2011) 5′-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. Int. J. Cancer 128, 2230-2239
10. Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., and Pietenpol, J. A. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767
11. Physical Sciences-Oncology Centers Network, Agus, D. B., Alexander, J. F., Arap, W., Ashili, S., Aslan, J. E., Austin, R. H., Backman, V., Bethel, K. J., Bonneau, R., Chen, W. C., Chen-Tanyolac, C., Choi, N. C., Curley, S. A., Dallas, M., Damania, D., Davies, P. C., Decuzzi, P., Dickinson, L., Estevez-Salmeron, L., Estrella, V., Ferrari, M., Fischbach, C., Foo, J., Fraley, S. I., Frantz, C., Fuhrmann, A., Gascard, P., Gatenby, R. A., Geng, Y., Gerecht, S., Gillies, R. J., Godin, B., Grady, W. M., Greenfield, A., Hemphill, C., Hempstead, B. L., Hielscher, A., Hillis, W. D., Holland, E. C., Ibrahim-Hashim, A., Jacks, T., Johnson, R. H., Joo, A., Katz, J. E., Kelbauskas, L., Kesselman, C., King, M. R., Konstantopoulos, K., Kraning-Rush, C. M., Kuhn, P., Kung, K., Kwee, B., Lakins, J. N., Lambert, G., Liao, D., Licht, J. D., Liphardt, J. T., Liu, L., Lloyd, M. C., Lyubimova, A., Mallick, P., Marko, J., McCarty, O. J., Meldrum, D. R., Michor, F., Mumenthaler, S. M., Nandakumar, V., O'Halloran, T. V., Oh, S., Pasqualini, R., Paszek, M. J., Philips, K. G., Poultney, C. S., Rana, K., Reinhart-King, C. A., Ros, R., Semenza, G. L., Senechal, P., Shuler, M. L., Srinivasan, S., Staunton, J. R., Stypula, Y., Subramanian, H., Tlsty, T. D., Tormoen, G. W., Tseng, Y., van Oudenaarden, A., Verbridge, S. S., Wan, J. C., Weaver, V. M., Widom, J., Will, C., Wirtz, D., Wojtkowiak, J., and Wu, P. H. (2013) A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci. Rep. 3, 1449
12. Robey, I. F., Stephen, R. M., Brown, K. S., Baggett, B. K., Gatenby, R. A., and Gillies, R. J. (2008) Regulation of the Warburg effect in early passage breast cancer cells. Neoplasia 10, 745-756
13. Jenkins, D. E., Hornig, Y. S., Oei, Y., Dusich, J., and Purchio, T. (2005) Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res. 7, R444-R454
14. Gucalp, A., and Traina, T. A. (2011) Triple-negative breast cancer: adjuvant therapeutic options. Chemother. Res. Pract. 2011, 696208
15. Duellman, S. J., Calaoagan, J. M., Sato, B. G., Fine, R., Klebansky, B., Chao, W. R., Hobbs, P., Collins, N., Sambucetti, L., and Laderoute, K. R. (2010) A novel steroidal inhibitor of estrogen-related receptor α (ERRα). Biochem. Pharmacol. 80, 819-826
16. Tomayko, M. M., and Reynolds, C. P. (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148-154 (Pubitemid 19163397)
17. Stackpole, C. W. (1981) Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature 289, 798-800
18. Lin, Z., Weinberg, J. M., Malhotra, R., Merritt, S. E., Holzman, L. B., and Brosius, F. C., 3rd. (2000) GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am. J. Physiol. Endocrinol. Metab. 278, E958-E966 (Pubitemid 30366415)
19. Laderoute, K. R., Calaoagan, J. M., Knapp, M., and Johnson, R. S. (2004) Glucose utilization is essential for hypoxia-inducible factor 1α-dependent phosphorylation of c-Jun. Mol. Cell. Biol. 24, 4128-4137 (Pubitemid 41070987)
20. Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X. Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., and Thompson, C. B. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A. 105, 18782-18787
21. Wu, M., Neilson, A., Swift, A. L., Moran, R., Tamagnine, J., Parslow, D., Armistead, S., Lemire, K., Orrell, J., Teich, J., Chomicz, S., and Ferrick, D. A. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292, C125-C136 (Pubitemid 46115126)
22. 18F-fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104. Clin. Cancer Res. 15, 7170-7174
23. Boros, L. G., Cascante, M., and Lee, W. N. (2002) Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov. Today 7, 364-372 (Pubitemid 34226656)
24. 13C isotopomer distribution analysis of lactate, glutamate and glucose. Food Chem. Toxicol. 49, 2968-2974
25. Bhalla, K., Hwang, B. J., Dewi, R. E., Ou, L., Twaddel, W., Fang, H. B., Vafai, S. B., Vazquez, F., Puigserver, P., Boros, L., and Girnun, G. D. (2011) PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res. 71, 6888-6898
26. 2]glucose. Am. J. Physiol. 274, E843-E851
27. Boren, J., Cascante, M., Marin, S., Comín-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W. N., and Boros, L. G. (2001) Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276, 37747-37753
28. Hardie, D. G., and Pan, D. A. (2002) Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30, 1064-1070 (Pubitemid 36002407)
29. 2]Glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats. Pancreas 31, 337-343
30. Langlois, A. J., Holder, W. D., Jr., Iglehart, J. D., Nelson-Rees, W. A., Wells, S. A., Jr., and Bolognesi, D. P. (1979) Morphological and biochemical properties of a new human breast cancer cell line. Cancer Res. 39, 2604-2613 (Pubitemid 9204200)
31. Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., Mamer, O. A., Avizonis, D., DeBerardinis, R. J., Siegel, P. M., and Jones, R. G. (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17, 113-124
32. Liang, J., and Mills, G. B. (2013) AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 73, 2929-2935
33. Wu, C. A., Chao, Y., Shiah, S. G., and Lin, W. W. (2013) Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochim. Biophys. Acta 1833, 1147-1156
34. Zhao, J., and Zhong, C. J. (2009) A review on research progress of transketolase. Neurosci. Bull. 25, 94-99
35. Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., Yusuf, F. I., Williams, R. D., Muscarella, P., Melvin, W. S., and Schirmer, W. J. (1997) Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 57, 4242-4248 (Pubitemid 27413432)
36. Liu, H., Huang, D., McArthur, D. L., Boros, L. G., Nissen, N., and Heaney, A. P. (2010) Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 70, 6368-6376
37. Sun, W., Liu, Y., Glazer, C. A., Shao, C., Bhan, S., Demokan, S., Zhao, M., Rudek, M. A., Ha, P. K., and Califano, J. A. (2010) TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1α stabilization. Clin. Cancer Res. 16, 857-866
38. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
39. Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., and Andreelli, F. (2010) AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 45, 276-295